SWMG
ABBV icon

Stillwater Wealth Management Group’s AbbVie ABBV Stock Holding History

Stillwater Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.18M Buy
19,200
+700
+4% +$155K 2.58% 16
2025
Q4 		$4.23M Sell
18,500
-52
-0.3% -$11.8K 2.87% 15
2025
Q3 		$4.3M Buy
+18,552
New +$3.78M 3.01% 11
2025
Q1 		$3.4M Buy
16,251
+812
+5% +$158K 2.95% 8
2024
Q4 		$2.74M Buy
+15,439
New +$2.84M 2.46% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stillwater Wealth Management Group's ABBV Position: Q1 2026 in Review

Stillwater Wealth Management Group increased its AbbVie (ABBV) stake by 3.8% in Q1 2026, buying an estimated $155K and bringing the position to 19,200 shares worth $4.18M. The position accounts for 2.58% of the portfolio, ranked #16.

Stillwater Wealth Management Group first reported a position in ABBV in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.3M in Q3 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Stillwater Wealth Management Group held 19,200 shares of AbbVie worth $4.18M as of Q1 2026.
  • Stillwater Wealth Management Group bought 700 AbbVie shares in Q1 2026, an estimated $155K.
  • AbbVie made up 2.58% of Stillwater Wealth Management Group's portfolio in Q1 2026, its #16 holding.
  • Stillwater Wealth Management Group first reported a position in AbbVie in Q4 2024 and has held it in 5 quarters since.
  • Stillwater Wealth Management Group's AbbVie position peaked at $4.3M in Q3 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stillwater Wealth Management Group's 13F filing for Q1 2026, filed 11 May 2026.